课题基金 / 基金详情

POTENT COMBINATION OF ANTIRETROVIRAL REGIMEN IN AFRICAN-AMERICAN MEN AND WOMEN

POTENT COMBINATION OF ANTIRETROVIRAL REGIMEN IN AFRICAN-AMERICAN MEN AND WOMEN
针对非裔美国男性和女性的抗逆转录病毒疗法的有效组合
批准号：
7625535
负责人：
DAVID A WOHL
金额：
$1.83万
依托单位：
UNIV OF NORTH CAROLINA CHAPEL HILL
依托单位国家：
美国
项目类别：
财政年份：
2006
资助国家：
美国
项目状态：
已结题
起止时间：
2006-12-01 至 2007-11-30
来源：
https://reporter.nih.gov/project-details/7625535
关键词：
African AmericanAnti-Retroviral AgentsBloodComputer Retrieval of Information on Scientific Projects DatabaseFundingGrantHIVInstitutionLamivudineLopinavirLopinavir/RitonavirPharmaceutical PreparationsPurposeResearchResearch PersonnelResourcesSourceTenofovirTreatment ProtocolsUnited States National Institutes of HealthWomanWorkdaymen

项目摘要

项目成果

DAVID A WOHL的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多利用 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 这项研究的主要目的是观察一种名为洛匹那韦的艾滋病毒药物在血液中的水平，当这种药物每天给药一次而不是每天两次时。 该研究还将研究Kaletra每天一次与另外两种每天一次的HIV药物3 TC和替诺福韦在控制HIV方面的效果如何。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The main purpose of the study is to look at the levels of an HIV drug call lopinavir in blood when the drug is given once a day rather than twice a day. The study will also look at how well Kaletra once a day works with two other once a day HIV medications called 3TC and tenofovir in controlling HIV.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mentoring New Investigators in Criminal Justice HIV Prevention and Treatment
Mentoring New Investigators in Criminal Justice HIV Prevention and Treatment
Mentoring New Investigators in Criminal Justice HIV Prevention and Treatment
FAT REDISTRIBUTION AND METABOLIC CHANGE IN HIV INFECTION
海外基金